Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDOGargi D Basu, Teresa L Tinder, Judy M Bradley, et al.Breast Cancer Research : BCR|December 13, 2006
A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cellsGargi D Basu, Winnie S Liang, Dietrich A Stephan, et al.Annals of Surgical Oncology|March 3, 2004
Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancerBarbara A Pockaj, Gargi D Basu, Latha B Pathangey, et al.International Journal of Cancer|March 22, 2016
Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancerPing Wang, Byunghee Yoo, Sarah Sherman, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinomaTeresa L Tinder, Durai B Subramani, Gargi D Basu, et al.Cancer Immunology, Immunotherapy : CII|May 1, 2012
Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activityJorge Schettini, Amritha Kidiyoor, Dahlia M Besmer, et al.Immunology|May 22, 2003
Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cellsDongshu Chen, Jianchuan Xia, Yasuhiro Tanaka, et al.Genes & Cancer|July 7, 2017
A tumor specific antibody to aid breast cancer screening in women with dense breast tissueLopamudra Das Roy, Lloye M Dillon, Ru Zhou, et al.Molecular Cancer Research : MCR|July 20, 2006
Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathwaysEric J Thompson, Kandavel Shanmugam, Christine L Hattrup, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibitionPinku Mukherjee, Gargi D Basu, Teresa L Tinder, et al.Pageof 7